Ligand id: 6879

Name: basiliximab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: basiliximab

No information available.
Summary of Clinical Use
Prophylaxis of acute organ rejection in adults following cadaveric- or living-donor renal transplantation
Mechanism Of Action and Pharmacodynamic Effects
Abrogates the critical cellular immune response involved in allograft rejection by acting as a functional IL-2 receptor antagonist, thereby inhibiting IL-2-mediated activation of lymphocytes.
External links